![Martin Lohse](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Lohse
Corporate Officer/Principal presso Julius-Maximilians-Universität Würzburg
Profilo
Martin Lohse is the founder of two companies, Corimmun GmbH founded in 2006 and advanceCOR GmbH founded in 2012.
He is currently the Head of Pharmacology & Toxicology Department at Julius-Maximilians-Universität Würzburg.
Posizioni attive di Martin Lohse
Società | Posizione | Inizio |
---|---|---|
Julius-Maximilians-Universität Würzburg | Corporate Officer/Principal | - |
Precedenti posizioni note di Martin Lohse
Società | Posizione | Fine |
---|---|---|
advanceCOR GmbH
![]() advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Fondatore | - |
Corimmun GmbH
![]() Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Corimmun GmbH
![]() Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Health Technology |
advanceCOR GmbH
![]() advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Health Technology |
- Borsa valori
- Insiders
- Martin Lohse